Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · IEX Real-Time Price · USD
19.87
-0.13 (-0.65%)
Mar 28, 2024, 10:35 AM EDT - Market open

Greenwich LifeSciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018
Selling, General & Admin
1.561.040.810.820.42
Research & Development
6.483.561.062.611.27
Operating Expenses
8.044.61.863.431.69
Operating Income
-8.04-4.6-1.86-3.43-1.69
Other Expense / Income
-0.22-0.03-0--
Pretax Income
-7.83-4.57-1.86-3.43-1.69
Net Income
-7.83-4.57-1.86-3.43-1.69
Shares Outstanding (Basic)
1313920
Shares Outstanding (Diluted)
1313920
Shares Change
-0.23%36.27%320.69%1012.33%-
EPS (Basic)
-0.61-0.35-0.20-1.52-8.32
EPS (Diluted)
-0.61-0.35-0.20-1.52-8.32
Free Cash Flow
-6.2-4.29-1.15-0.29-0.11
Free Cash Flow Per Share
-0.48-0.33-0.12-0.13-0.57
EBITDA
-7.82-4.57-1.86-3.42-1.69
Depreciation & Amortization
00000
EBIT
-7.83-4.57-1.86-3.43-1.69
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).